Next Article in Journal
Access to Oncology Consultation in a Cancer Cohort in Northeastern Ontario
Previous Article in Journal
Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Adherence to and Uptake of Clinical Practice Guidelines: Lessons Learned from a Clinical Practice Guideline on Chemotherapy Concomitant with Radiotherapy in Head-and-Neck Cancer

1
Department of Otolaryngology, Queen’s University, Kingston, ON, Canada
2
Division of Cancer Care and Epidemiology, Queen’s University, Kingston, ON, Canada
3
Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
4
Department of Oncology, Queen’s University, Kingston, ON, Canada
5
Division of Cancer Care and Epidemiology, Queen’s University, Kingston, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2015, 22(2), 61-68; https://doi.org/10.3747/co.22.2235
Submission received: 6 January 2015 / Revised: 2 February 2015 / Accepted: 9 March 2015 / Published: 2 April 2015

Abstract

Background: Clinical practice guidelines (cpgs) are systematically developed statements designed to assist practitioners and patients in making decisions about appropriate heath care interventions. Clinical practice guidelines are expensive and time-consuming to create. A cpg on concurrent chemotherapy with radiation therapy (ccrt) was developed in Ontario at a time when treatment approaches for head-and-neck cancer were changing significantly. Methods: An assessment of treatments and outcomes based on electronic and chart data obtained from a population-based study of 571 patients with oropharynx cancer treated in Ontario (2003–2004) was combined with a review of relevant knowledge transfer (publications and presentations at major meetings) to understand variation in adherence to a cpg. Results: In 9 Ontario cancer treatment centres, ccrt was used for 55% of all patients with oropharyngeal cancer; however, at the centres individually, that proportion ranged from 82% to 39%. Furthermore, there was no agreement on the chemotherapy regimen: 2–4 years later (a period during which newer regimens were emerging), only 4 of 9 centres were following the guideline for most patients. When outcomes of treated patients were compared for centres with “higher” and “lower” use of ccrt, no difference in survival was observed (p = 0.64). Conclusions: At a time of treatment evolution, the new guideline was controversial, and there are many reasons for the mixed adherence. An estimation of adherence should be included during both development and review of guidelines.
Keywords: clinical practice guidelines; uptake; variation; head-and-neck cancer; chemoradiotherapy clinical practice guidelines; uptake; variation; head-and-neck cancer; chemoradiotherapy

Share and Cite

MDPI and ACS Style

Hall, S.F.; Irish, J.C.; Gregg, R.W.; Groome, P.A.; Rohland, S. Adherence to and Uptake of Clinical Practice Guidelines: Lessons Learned from a Clinical Practice Guideline on Chemotherapy Concomitant with Radiotherapy in Head-and-Neck Cancer. Curr. Oncol. 2015, 22, 61-68. https://doi.org/10.3747/co.22.2235

AMA Style

Hall SF, Irish JC, Gregg RW, Groome PA, Rohland S. Adherence to and Uptake of Clinical Practice Guidelines: Lessons Learned from a Clinical Practice Guideline on Chemotherapy Concomitant with Radiotherapy in Head-and-Neck Cancer. Current Oncology. 2015; 22(2):61-68. https://doi.org/10.3747/co.22.2235

Chicago/Turabian Style

Hall, S.F., J.C. Irish, R.W. Gregg, P.A. Groome, and S. Rohland. 2015. "Adherence to and Uptake of Clinical Practice Guidelines: Lessons Learned from a Clinical Practice Guideline on Chemotherapy Concomitant with Radiotherapy in Head-and-Neck Cancer" Current Oncology 22, no. 2: 61-68. https://doi.org/10.3747/co.22.2235

Article Metrics

Back to TopTop